Mariner’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-24,351
Closed -$2.42M 741
2019
Q3
$2.42M Sell
24,351
-10,037
-29% -$954K 0.03% 344
2019
Q2
$3.18M Sell
34,388
-90,768
-73% -$8.62M 0.04% 323
2019
Q1
$11.8M Sell
125,156
-89,759
-42% -$7.85M 0.17% 150
2018
Q4
$13.8M Buy
214,915
+98,373
+84% +$7.26M 0.25% 114
2018
Q3
$10.4M Buy
116,542
+9,269
+9% +$819K 0.27% 91
2018
Q2
$8.52M Buy
107,273
+11,508
+12% +$956K 0.24% 99
2018
Q1
$8.54M Buy
95,765
+51,087
+114% +$4.9M 0.31% 79
2017
Q4
$4.66M Buy
44,678
+10,878
+32% +$1.23M 0.18% 105
2017
Q3
$4.93M Buy
33,800
+5,594
+20% +$762K 0.22% 87
2017
Q2
$3.66M Buy
28,206
+3,349
+13% +$410K 0.17% 105
2017
Q1
$3.09M Buy
24,857
+3,275
+15% +$392K 0.13% 138
2016
Q4
$2.5M Sell
21,582
-1,622
-7% -$181K 0.12% 156
2016
Q3
$2.42M Buy
23,204
+4,128
+22% +$447K 0.12% 160
2016
Q2
$1.88M Buy
19,076
+1,003
+6% +$104K 0.1% 177
2016
Q1
$1.81M Buy
18,073
+2,373
+15% +$244K 0.11% 175
2015
Q4
$1.88M Sell
15,700
-72,050
-82% -$8.34M 0.12% 152
2015
Q3
$9.49M Buy
87,750
+3,157
+4% +$392K 0.42% 72
2015
Q2
$9.79M Buy
84,593
+75,044
+786% +$8.58M 0.45% 64
2015
Q1
$1.1M Sell
9,549
-361
-4% -$43.1K 0.09% 173
2014
Q4
$1.11M Buy
9,910
+5,764
+139% +$608K 0.1% 164
2014
Q3
$393K Sell
4,146
-4,476
-52% -$404K 0.04% 238
2014
Q2
$740K Buy
8,622
+4,340
+101% +$330K 0.08% 180
2014
Q1
$299K Sell
4,282
-4,068
-49% -$322K 0.04% 254
2013
Q4
$705K Sell
8,350
-1,736
-17% -$137K 0.09% 187
2013
Q3
$777K Sell
10,086
-1,762
-15% -$123K 0.14% 148
2013
Q2
$693K Buy
+11,848
New +$713K 0.15% 143

Other funds holding CELG

Mariner's CELG Position: Q4 2019 in Review

Mariner sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 24,351 shares — an estimated $2.42M sold.

Mariner first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.8M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mariner reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mariner sold 24,351 Celgene Corp shares in Q4 2019, an estimated $2.42M.
  • Mariner first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Mariner's Celgene Corp position peaked at $13.8M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mariner's 13F filing for Q4 2019, filed 13 Feb 2020.